Effects of Galantamine and Donepezil on the Amount and the Quality on the Sleep in Patients Suffering From Alzheimer Disease.

Trial Profile

Effects of Galantamine and Donepezil on the Amount and the Quality on the Sleep in Patients Suffering From Alzheimer Disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Aug 2014

At a glance

  • Drugs Donepezil (Primary) ; Galantamine (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 03 Sep 2013 Planned end date changed from 1 Sep 2009 to 1 Sep 2014 as reported by ClinicalTrials.gov.
    • 25 Sep 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top